drugset / Trial / NCT01951742
Dose Finding Study In Subjects With Crow's Feet
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to establish the therapeutic range of ANT-1401 in the treatment of Crow's Feet.
Timeline
- Start
- 2013-09
- Primary completion
- 2013-12
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | — |